Kuros Biosciences Ltd. | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,000.00
1,000.00
144.00
1,061.00
534.00
715
SG&A Expense
26,239.00
22,838.00
4,312.00
21,012.00
16,368.00
13,869
EBIT
25,324.00
21,847.00
-
20,771.00
16,981.00
15,197
Unusual Expense
-
396.00
50.00
3,147.00
2,197.00
-
Non Operating Income/Expense
2,058.00
2,514.00
-
2,572.00
2,542.00
1,344
Interest Expense
7,825.00
15,185.00
1,762.00
145.00
-
-
Pretax Income
30,831.00
34,034.00
5,830.00
20,277.00
16,593.00
13,813
Income Tax
-
-
46.00
533.00
109.00
2,120
Equity in Affiliates
5.00
8.00
-
-
-
-
Consolidated Net Income
30,826.00
34,026.00
5,784.00
19,744.00
16,484.00
11,693
Net Income
30,826.00
34,026.00
5,784.00
19,744.00
16,484.00
11,693
Net Income After Extraordinaries
30,826.00
34,026.00
5,784.00
19,744.00
16,484.00
11,693
Net Income Available to Common
30,826.00
34,026.00
5,784.00
19,744.00
16,484.00
11,693
EPS (Basic)
128.52
108.07
273.58
3.85
2.32
1.34
Basic Shares Outstanding
239.80
313.50
21.10
5,140.00
7,091.40
8,724.40
EPS (Diluted)
128.53
108.53
273.48
3.84
2.32
1.34
Diluted Shares Outstanding
239.80
313.50
21.10
5,140.00
7,091.40
8,724.40
EBITDA
25,239.00
21,838.00
4,168.00
19,951.00
15,834.00
13,250
Non-Operating Interest Income
260.00
88.00
154.00
1,214.00
43.00
40
About Kuros Biosciences
View Profile
